Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

399
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
399
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

155
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
155
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

248
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
248
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

1.1K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.1K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

462
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
462
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

226
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
226

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Leukemia·2022
Same author

Does the smell of alcohol make it harder to resist? The impact of olfactory cues on inhibitory control and attentional bias.

Psychopharmacology·2022
Same author

[Outcome of a survey on antibiotic prescribing in veterinary medicine].

Schweizer Archiv fur Tierheilkunde·2022
Same author

[Survey on the use of antibiotics in exotic pets among Swiss veterinarians].

Schweizer Archiv fur Tierheilkunde·2021
Same author

The bovine cumulus proteome is influenced by maturation condition and maturational competence of the oocyte.

Scientific reports·2020
Same author

[Antibiotic-resistant bacteria in dogs and cats: recommendations for -owners].

Schweizer Archiv fur Tierheilkunde·2020
Same journal

[Actinomycosis in cattle - Five clinical cases].

Schweizer Archiv fur Tierheilkunde·2026
Same journal

Clinical, hematological and biochemical findings in bovines with primary abomasal impaction.

Schweizer Archiv fur Tierheilkunde·2026
Same journal

[Severe lameness in cattle is associated with severe orthopaedic disorders and a poor prognosis].

Schweizer Archiv fur Tierheilkunde·2026
Same journal

[Elemente einer politischen Ökonomie von One Health mit einem Bezug zur Schweiz].

Schweizer Archiv fur Tierheilkunde·2026
Same journal

[Nutritional lifestyle and «production animal» tracking during veterinary curriculum].

Schweizer Archiv fur Tierheilkunde·2026
Same journal

[How do veterinarians in Switzerland manage leishmaniosis? A survey-based overview of our -treatment approaches with a focus on the management of proteinuria].

Schweizer Archiv fur Tierheilkunde·2026
See all related articles

Related Experiment Video

Updated: Jan 24, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.2K

[The reclassification assistant: Drug reclassification made easy].

P Schnetzer1, F Stucki2, D Heim2

  • 1Institut für Veterinärpharmakologie und -toxikologie, Vetsuisse-Fakultät, Universität Zürich.

Schweizer Archiv Fur Tierheilkunde
|May 31, 2019
PubMed
Summary
This summary is machine-generated.

Veterinarians can use a new online assistant to determine if and how to reclassify veterinary medicines for livestock and horses when authorized options are unavailable. This tool ensures compliance with food safety regulations and provides crucial withdrawal period information.

Keywords:
AbsetzfristenAnimaux de renteCascade de reconversionDélai d’attenteEquidaeEquidenEquidésFarm animalsFood safetyLebensmittel­sicherheitNutztiereReclassification cascadeSécurité alimentaireTermini di attesaUmwidmungskaskadeWithdrawal periodanimali da redditocascata per il cambiamento di destinazioneequinisicurezza delle derrate alimentari

More Related Videos

Easy and Reproducible Low-Density Primary Culture using Frozen Stock of Embryonic Hippocampal Neurons
04:26

Easy and Reproducible Low-Density Primary Culture using Frozen Stock of Embryonic Hippocampal Neurons

Published on: January 27, 2023

2.9K
An Easy Method for Plant Polysome Profiling
11:09

An Easy Method for Plant Polysome Profiling

Published on: August 28, 2016

13.3K

Related Experiment Videos

Last Updated: Jan 24, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.2K
Easy and Reproducible Low-Density Primary Culture using Frozen Stock of Embryonic Hippocampal Neurons
04:26

Easy and Reproducible Low-Density Primary Culture using Frozen Stock of Embryonic Hippocampal Neurons

Published on: January 27, 2023

2.9K
An Easy Method for Plant Polysome Profiling
11:09

An Easy Method for Plant Polysome Profiling

Published on: August 28, 2016

13.3K

Area of Science:

  • Veterinary Medicine
  • Pharmacology
  • Food Safety Regulations

Background:

  • Over 700 veterinary medicinal products are authorized in Switzerland.
  • Veterinarians face challenges with unavailable or inapplicable authorized medicines, especially for livestock and horses.
  • Food safety regulations complicate pharmacotherapy in these extraordinary situations.

Purpose of the Study:

  • To introduce an online reclassification assistant for veterinary medicinal products.
  • To guide veterinarians through the process of reclassifying medicines for food-producing animals.
  • To ensure pharmacotherapy compliance with legal frameworks and food safety.

Main Methods:

  • Development of an online assistant with a step-by-step, selectable option guidance.
  • Algorithm based on the reclassification cascade and Swiss food safety regulations.
  • Integration of information on withdrawal periods for reclassified medicines.

Main Results:

  • The assistant determines the permissibility of reclassification within the legal framework.
  • Provides essential information on withdrawal periods for selected veterinary medicines.
  • Facilitates correct application of medicinal products in food-producing animals.

Conclusions:

  • The online reclassification assistant addresses critical pharmacotherapy challenges for veterinarians.
  • It supports safe and legal use of veterinary medicines in food-producing animals.
  • Ensures adherence to food safety and regulatory requirements in veterinary practice.